Jim Young

10PUBLICATIONS
27CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Predictive and prognostic markersDisease surveillanceEpidemiological modellingMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 24, 2026
It's about time: The association between abacavir and cardiovascular disease.

|Apr 10, 2026
The risk of HIV and HCV transmission in Canadians living with coinfection before, during, and after the COVID pandemic: A prospective cohort study.

Jim Young, Shouao Wang, Matthew Knight

|Nov 18, 2025
Risk of Hepatocellular Carcinoma After Direct-Acting Antiviral Treatment for Hepatitis C Virus Infection in People With HIV.

Daniela K van Santen, Mathieu Chalouni, Juan Berenguer

|Feb 20, 2025
Liver Fibrosis Regression in People Living With HIV After Successful Treatment for Hepatitis C.

Jim Young, Shouao Wang, Rachel Sacks-Davis

|Oct 17, 2024
Changes in Hepatic Steatosis Before and After Direct-Acting Antiviral Treatment in People With HIV and Hepatitis C Coinfection.

Esther Truscello, Shouao Wang, Jim Young

|Dec 20, 2022
Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286).

Marina B Klein, Jim Young, David Ortiz-Paredes

Pageof 2

Frequent Collaborators

6 joint publications

Marina B Klein

2 joint publications

Juan Berenguer

2 joint publications

Linda Wittkop

1 joint publications

David Ortiz-Paredes